Sequent Scientific’s arm inks pact to acquire 100% stake in Nourrie

16 Dec 2021 Evaluate

Sequent Scientific’s subsidiary -- Evance Saude Animal Health Ltda (Evance), Brazil has entered into a definitive agreement for acquisition of 100% stake in Nourrie Saude e Nutricao Animal Ltda (Nourrie).

The acquisition will be made through Evance, subsidiary of Alivira Brazil, for a cash consideration of BRL 27 Million, and is expected to close in Q4 FY22. The object of the said acquisition is to enhance Alivira’s presence in Brazil and entry into pet market--fastest growing segment in Brazil, 4th largest in the world. 

Sequent Scientific is an integrated pharmaceutical company with a global footprint headquartered in Bangalore, India which has presence in different pharmaceutical verticals including APIs, Animal Health, Analytical Services, CRAMS and specialty chemicals. Sequent is the world's largest producer of Anthelmintics and by far the strongest player in the Veterinary API business.

Sequent Scientific Share Price

199.65 -8.00 (-3.85%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×